Informations:
Erreur:
ID
22426
Description
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study; ODM derived from: https://clinicaltrials.gov/show/NCT00246805
Lien
https://clinicaltrials.gov/show/NCT00246805
Mots-clés
Versions (1)
- 02/06/2017 02/06/2017 -
Téléchargé le
2 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Permanent Atrial Fibrillation NCT00246805
Eligibility Permanent Atrial Fibrillation NCT00246805
- StudyEvent: Eligibility
Similar models
Eligibility Permanent Atrial Fibrillation NCT00246805
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Informed Consent
Item
patient has signed informed consent form
boolean
C0021430 (UMLS CUI [1])
Permanent atrial fibrillation | Indication Pacemaker VVI | Indication Pacemaker VVIR | Irregular heart beat Episode of Quantity
Item
patient with permanent atrial fibrillation, standard indication for vvi(r) pacing, and at least 1 episode of rate irregularity in the last month
boolean
C2586056 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0747134 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0747139 (UMLS CUI [3,2])
C0237314 (UMLS CUI [4,1])
C0332189 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
C3146298 (UMLS CUI [2,1])
C0747134 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0747139 (UMLS CUI [3,2])
C0237314 (UMLS CUI [4,1])
C0332189 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
New York Heart Association Classification
Item
new york heart association (nyha) class i, ii, iii
boolean
C1275491 (UMLS CUI [1])
Protocol Compliance
Item
patient is able to comply with follow-up times and will comply with the protocol
boolean
C0525058 (UMLS CUI [1])
Age
Item
> 18 years of age
boolean
C0001779 (UMLS CUI [1])
Paroxysmal atrial fibrillation
Item
paroxysmal atrial fibrillation
boolean
C0235480 (UMLS CUI [1])
New York Heart Association Classification
Item
nyha class iv
boolean
C1275491 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) < 35
boolean
C0428772 (UMLS CUI [1])
Angina, Unstable
Item
patients with unstable angina
boolean
C0002965 (UMLS CUI [1])
Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous Transluminal Coronary Angioplasty
Item
patients who have experienced an acute myocardial infarction or received coronary artery revascularization (cabg), or coronary angioplasty (ptca) within 3 months prior to enrolment
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C2936173 (UMLS CUI [3])
C0010055 (UMLS CUI [2])
C2936173 (UMLS CUI [3])
Indication Cardiac Surgery procedures | Indication Percutaneous Transluminal Coronary Angioplasty
Item
patient candidate for cardiac surgery, or coronary angioplasty (ptca)
boolean
C3146298 (UMLS CUI [1,1])
C0018821 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C2936173 (UMLS CUI [2,2])
C0018821 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C2936173 (UMLS CUI [2,2])
Cerebrovascular accident | Transient Ischemic Attack | Permanent disability
Item
patients who experienced a cardiovascular accident (cva) or transient ischemic attack (tia) with permanent disability
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
C2135346 (UMLS CUI [3])
C0007787 (UMLS CUI [2])
C2135346 (UMLS CUI [3])
Life Expectancy Due to Other medical condition
Item
life expectancy < 12 months due to other medical conditions
boolean
C0023671 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
the patient is enrolled in any concurrent (drug and/or device) study
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])